721 related articles for article (PubMed ID: 10760806)
1. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
[TBL] [Abstract][Full Text] [Related]
2. Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry.
Königs C; Pustowka A; Irving J; Kessel C; Klich K; Wegner V; Rowley MJ; Mackay IR; Kreuz W; Griesinger C; Dietrich U
Immunol Cell Biol; 2007 Oct; 85(7):511-7. PubMed ID: 17607321
[TBL] [Abstract][Full Text] [Related]
3. Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen.
Davies JM; Rowley MJ; MacKay IR
Immunol Cell Biol; 1999 Dec; 77(6):483-90. PubMed ID: 10571668
[TBL] [Abstract][Full Text] [Related]
4. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U
J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187
[TBL] [Abstract][Full Text] [Related]
5. Requirement of multiple phage displayed peptide libraries for optimal mapping of a conformational antibody epitope on CCR5.
O'Connor KH; Königs C; Rowley MJ; Irving JA; Wijeyewickrema LC; Pustowka A; Dietrich U; Mackay IR
J Immunol Methods; 2005 Apr; 299(1-2):21-35. PubMed ID: 15914189
[TBL] [Abstract][Full Text] [Related]
6. Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry.
Xu Y; Ramsland PA; Davies JM; Scealy M; Nandakumar KS; Holmdahl R; Rowley MJ
Mol Immunol; 2004 Jun; 41(4):411-9. PubMed ID: 15163538
[TBL] [Abstract][Full Text] [Related]
7. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
[TBL] [Abstract][Full Text] [Related]
8. Mimotopes identified by phage display for the monoclonal antibody CII-C1 to type II collagen.
Cook AD; Davies JM; Myers MA; Mackay IR; Rowley MJ
J Autoimmun; 1998 Jun; 11(3):205-11. PubMed ID: 9693968
[TBL] [Abstract][Full Text] [Related]
9. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
Siciliano SJ; Kuhmann SE; Weng Y; Madani N; Springer MS; Lineberger JE; Danzeisen R; Miller MD; Kavanaugh MP; DeMartino JA; Kabat D
J Biol Chem; 1999 Jan; 274(4):1905-13. PubMed ID: 9890944
[TBL] [Abstract][Full Text] [Related]
10. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
[TBL] [Abstract][Full Text] [Related]
11. Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.
Khurana S; Kennedy M; King LR; Golding H
J Virol; 2005 Jun; 79(11):6791-800. PubMed ID: 15890918
[TBL] [Abstract][Full Text] [Related]
12. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
Cormier EG; Tran DN; Yukhayeva L; Olson WC; Dragic T
J Virol; 2001 Jun; 75(12):5541-9. PubMed ID: 11356961
[TBL] [Abstract][Full Text] [Related]
13. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.
Abayev M; Moseri A; Tchaicheeyan O; Kessler N; Arshava B; Naider F; Scherf T; Anglister J
FEBS J; 2015 May; 282(10):1906-1921. PubMed ID: 25703038
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
[TBL] [Abstract][Full Text] [Related]
15. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
16. Study on CCR5 analogs and affinity peptides.
Wu Y; Deng R; Wu W
Protein Eng Des Sel; 2012 Mar; 25(3):97-105. PubMed ID: 22238429
[TBL] [Abstract][Full Text] [Related]
17. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
Morikis D; Rizos AK; Spandidos DA; Krambovitis E
Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
[TBL] [Abstract][Full Text] [Related]
19. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.
Cormier EG; Persuh M; Thompson DA; Lin SW; Sakmar TP; Olson WC; Dragic T
Proc Natl Acad Sci U S A; 2000 May; 97(11):5762-7. PubMed ID: 10823934
[TBL] [Abstract][Full Text] [Related]
20. Dual specificity of a human neutralizing monoclonal antibody, specific for the V3 loop of GP120 (HIV-1).
Laisney IL; Strosberg AD
Immunol Lett; 1999 Apr; 67(3):185-92. PubMed ID: 10369125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
